Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Clinical Trials
400 Articles Available
1
17
Can't find what you're looking for? Try our
advanced search
.
Clinical Trials
Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis
PR-M10-19-NI-017
Clinical Trial Partnership
Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials
PR-M10-19-NI-014
Clinical Trials
Sosei Heptares Notes the Announcement of Positive Results from Phase III IRIDIUM Study of Inhaled Combination QVM149 in Patients with Uncontrolled Asthma
PR-M10-19-NI-011
FDA
FDA Encourages Inclusion of Male Patients in Breast Cancer Clinical Trials
PR-M10-19-NI-005
Clinical Trials
Poorly Reported Placebos May Lead to Mistaken Estimates of Benefits
PR-M10-19-NI-004
Clinical Data
New Data Reinforces Benefits of Spiolto® Respimat® in Improving Patient Outcomes
PR-M10-19-NI-001
Liquid Biopsy
GRAIL Announces Positive New Data with Multi-Cancer Early Detection Blood Test from CCGA Study
PR-M09-19-NI-058
Positive Results
Amgen Announces Positive Results From Two Phase 3 BLINCYTO® Studies In Pediatric Patients
PR-M09-19-NI-056
Epigenetics
Turning Back the Epigenetic Clock?
PAO-M09-19-NI-018
Clinical Trial
Arial Halts Trial for First Drug to Treat DRP Early
PAO-M09-19-NI-015
Positive Results
Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)
PR-M09-19-NI-039
Clinical Trials
ACADIA Pharmaceuticals Announces Meets the Primary Phase 3 Endpoint in Patients with Dementia-Related Psychosis
PR-M09-19-NI-036
Patient Enrollment
Inhibrx Announces Enrollment of First Patient in Phase 1 Study of INBRX-101, a Modified Recombinant Human AAT-Fc Fusion Protein
PR-M09-19-NI-023
Clinical Data
Ultragenyx Announces Positive Data from Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
PR-M09-19-NI-020
Clinical Trials
uniQure Announces Achievement of Planned Enrollment in HOPE-B Pivotal Trial of AMT-061 (Etranacogene Dezaparvovec) in Patients with Hemophilia B
PR-M09-19-NI-013
Clinical Data
Concert Pharmaceuticals Reports Positive CTP-543 Results from Phase 2 Alopecia Areata Trial
PR-M09-19-NI-010
Clinical Trials
Soligenix Announces Positive Recommendation on its Phase 3 Clinical Trial for the Treatment of Oral Mucositis
PR-M09-19-NI-007
Collaboration
Presage Announces Collaboration with Bristol-Myers Squibb for Phase O Studies of Novel Cancer Agents Utilizing CIVO™ Technology
PR-M09-19-NI-002
Endpoints
InDex Pharmaceuticals Meets Primary Endpoint in the Phase IIb Study CONDUCT with Cobitolimod in Ulcerative Colitis
PR-M08-19-NI-086
Announcement
GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple Myeloma
PR-M08-19-NI-075
Clinical Trials
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients With Severe, Inherited form of High Cholesterol
PR-M08-19-NI-049
Oncology
Tagrisso Significantly Improves Overall Survival in the Phase III FLAURA Trial for 1st-line EGFR-Mutated Non-Small Cell Lung Cancer
PR-M08-19-NI-041
Clinical Trials
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities
PR-M08-19-NI-032
Partnership
Tryon Medical Partners Announces Partnership with Javara to Offer Clinical Trials to Patients
PR-M08-19-NI-027
1
17
»
